Muscle Contraction Tension Headache

Author: Manish K Singh, MD; Chief Editor: Howard A Crystal, MD

Background
Tension-type headache (TTH) represents one of the most costly diseases because of its very high prevalence. TTH is the most common type of headache, and it is classified as episodic (ETTH) or chronic (CTTH). It had various ill-defined names in the past including tension headache, stress headache, muscle contraction headache, psychomyogenic headache, ordinary headache, and psychogenic headache. See Medscape's Headache Resource Center for more information. The International Headache Society (IHS) defines TTH more precisely and differentiates between the episodic and the chronic types. The following is a modified outline of the IHS diagnostic criteria:
Episodic tension-type headache

At least 10 previous headaches fulfilling the following criteria; number of days with such headache fewer than 15 per month Headaches lasting from 30 minutes to 7 days At least 2 of the following pain characteristics: o Pressing/tightening (nonpulsating) quality o Mild or moderate intensity (may inhibit but does not prohibit activities) o Bilateral location o No aggravation from climbing stairs or similar routine physical activity Both of the following: o No nausea or vomiting o Photophobia and phonophobia absent or only one present Secondary headache types not suggested or confirmed

Chronic tension-type headache

Average headache frequency of more than 15 days per month for more than 6 months fulfilling the following criteria At least 2 of the following pain characteristics: o Pressing/tightening (nonpulsating) quality o Mild or moderate intensity (may inhibit but does not prohibit activities) o Bilateral location o No aggravation from climbing stairs or similar routine physical activity Both of the following: o No vomiting o No more than one of the following: nausea, photophobia, or phonophobia Secondary headache types not suggested or confirmed

Pathophysiology
Pathogenesis of TTH is complex and multifactorial, with contributions from both central and peripheral factors. In the past, various mechanisms including vascular, muscular (ie, constant overcontraction of scalp muscles), and psychogenic factors were suggested. The more likely cause of these headaches is believed now to be abnormal neuronal sensitivity and pain facilitation, not abnormal muscle contraction. Various evidence suggests that, like migraine, TTH is associated with exteroceptive suppression (ES2), abnormal platelet serotonin, and decreased cerebrospinal fluid betaendorphin. In one study, plasma levels of substance P, neuropeptide Y, and vasoactive intestinal peptide were found to be normal in patients with CTTH and unrelated to the headache state. Several concurrent pathophysiologic mechanisms may be responsible for TTH; according to Jensen, extracranial myofascial nociception is one of them. Headache is not related directly to muscle contraction, and possible hypersensitivity of neurons in the trigeminal nucleus caudalis has been suggested. Bendtsen described central sensitization at the level of the spinal dorsal horn/trigeminal nucleus due to prolonged nociceptive inputs from pericranial myofascial tissues.[1] The central neuroplastic changes may affect regulation of peripheral mechanisms and can lead to increased pericranial muscle activity or release of neurotransmitters in myofascial tissues. This central sensitization may be maintained even after the initial eliciting factors have been normalized, resulting in conversion of ETTH into CTTH. Further research is necessary to understand and clarify the mechanisms of TTH. Research may lead to the development of more specific and effective management in the future.

Epidemiology
Frequency United States

TTH is the most common primary headache syndrome.

International

Rasmussen et al reported a lifetime prevalence of TTH of 69% in men and 88% in women in the Danish population.[2] The patient may experience more than one primary headache syndrome. In one study by Ulrich et al, the 1-year prevalence of TTH was the same among individuals with and without migraine.[3]
Sex

Women are slightly more likely to be affected than men.

The female-to-male ratio for TTH is approximately 1.4:1. In CTTH, female preponderance is 1.9:1.

Age

TTH can occur at any age, but onset during adolescence or young adulthood is common. It can begin in childhood.

History
Tension-type headaches (TTHs) are characterized by pain that is usually mild or moderate in severity and bilateral in distribution. Unilateral pain may be experienced by 10-20% of patients. Headache is a constant, tight, pressing, or bandlike sensation in the frontal, temporal, occipital, or parietal area (with frontal and temporal regions most common).

Ulrich et al reported that 82% of TTHs last less than 24 hours.[3] The deep steady ache differs from the typical throbbing quality of migraine headache. o Prodrome and aura are absent. o Occasionally, the headache may be throbbing or unilateral, but most patients do not report photophobia, sonophobia, or nausea, which commonly are associated with migraine. Some patients may have neck, jaw, or temporomandibular joint discomfort.

Physical

Patients with TTH have normal findings on general and neurologic examinations. Some patients may have tender spots or taut bands in the pericranial or cervical muscles (trigger points).

Causes
Various precipitating factors may cause TTH in susceptible individuals. One half of patients with TTH identify stress or hunger as a precipitating factor.

Stress - Usually occurs in the afternoon after long stressful work hours Sleep deprivation Uncomfortable stressful position and/or bad posture Irregular meal time (hunger) Eyestrain

Aseptic Meningitis Lyme Disease Migraine Headache Migraine Variants Pseudotumor Cerebri

Medical Care

Management of TTH consists of pharmacotherapy, psychophysiologic therapy, and physical therapy. o Treatment of headache must be tailored for individual patients.

Recognition of comorbid illness is essential. Migraine may be associated with TTH, and management overlaps. Other associated conditions may include depression, anxiety, and emotional or adjustment disorders. o Management of CTTH with a combination of tricyclic antidepressant medication and stress management therapy may result in a better outcome than monotherapy.[4] Pharmacotherapy consists of abortive therapy (to stop or reduce severity of the individual attack) and long-term preventive therapy. Preventive drugs are the main therapy for CTTH, but they seldom are needed for ETTH. o These headaches (especially ETTH) generally respond to simple over-the-counter (OTC) analgesics such as paracetamol (ie, acetaminophen), ibuprofen, aspirin, or naproxen. o If treatment is unsatisfactory, the addition of caffeine or use of prescription drugs is recommended. If possible, avoid use of barbiturates or opiate agonists. o Also discourage overuse of all symptomatic analgesics because of the risk of dependence, abuse, and development of chronic daily headache. o Fiorinal with codeine is generally significantly more effective than placebo or Fiorinal alone. The combination is also significantly better than codeine alone in relieving pain and maintaining ability to perform daily activities. However, Fiorinal with codeine is not first-line therapy and carries a significant risk of abuse. Consider preventive medications if the headaches are frequent (>2 attacks per wk), of long duration (>3-4 h), or severe enough to cause significant disability or overuse of abortive medication. o Amitriptyline (Elavil) and nortriptyline (Pamelor) are the most frequently used tricyclic antidepressants. o The selective serotonin reuptake inhibitors (SSRIs) fluoxetine (Prozac), paroxetine (Paxil), and sertraline (Zoloft) also are used commonly by many physicians. In a double-blind placebo-controlled trial conducted by Saper et al of fluoxetine in patients with chronic daily headache and migraine, it was reported to be helpful.[5] o Other antidepressants such as doxepin, desipramine, protriptyline, and buspirone also can be used. According to Cohen, protriptyline may be comparable in effectiveness to amitriptyline in CTTH without producing drowsiness and weight gain. o As reported by Bendtsen et al, in one double-blind trial that compared citalopram to amitriptyline and a placebo, patients on citalopram demonstrated lower headache scores than those on placebo, but amitriptyline was significantly more effective.[6] o Tizanidine may improve inhibitory function in the central nervous system and can provide pain relief. One recent study by Saper et al provides support for the efficacy of tizanidine in the prophylaxis of chronic daily headache.[7] Currently the use of tizanidine remains investigational in the treatment of this disorder. Physical therapy techniques include hot or cold applications, positioning, stretching exercises, traction, massage, ultrasound therapy, transcutaneous electrical nerve stimulation (TENS), and manipulations. o Heat, massage, and stretching can be used to alleviate excess muscle contraction and pain. o Cranial electrotherapy stimulation is different from TENS, is safe, and may be effective in alleviating the pain intensity of TTH. It may be considered as an alternative to long-term analgesic use. Psychophysiologic therapy includes reassurance, counseling, relaxation therapy, stress management programs, and biofeedback techniques. With these modalities of treatment, both frequency and severity of chronic headache may be reduced.

In a few studies, such as that by Holroyd et al, benefits from cognitive-behavioral therapy and biofeedback therapy have been reported.[4] o Biofeedback may be helpful in some patients when combined with medications. o One prospective study of TTH in an elderly population suggested that relaxation therapy may be an effective intervention. The following various minimally invasive techniques may provide pain relief: o Trigger point injections o Greater or lesser occipital nerve blocks o Auriculotemporal nerve block o Supraorbital nerve block o Botulinum toxin injection in the pericranial muscle o Other alternative treatments: In one study, Biondi and Portuesi suggested that acupuncture results are difficult to assess and that acupuncture should be reserved for selected patients.[8]

Consultations
Psychiatry consultations: CTTH can mask or be associated with comorbid conditions such as depression, anxiety, or other serious emotional disorders.

Diet
Balanced meals

Activity
These nonpharmacologic methods have shown improvement of central nervous-system related symptoms:

Regular exercise Adequate sleep: The patient should maintain a regular sleep schedule. Relaxation training[9]

Medication Summary
The goals of pharmacotherapy for tension-type headaches (TTHs) are to relieve the headache, reduce morbidity, and prevent complications.

Analgesics
Class Summary

These agents can be used for abortive therapy.

View full drug information Acetaminophen (Tylenol, Aspirin Free Anacin, Feverall, Tempra)

First choice for treatment of headache, especially during pregnancy and breastfeeding.

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Class Summary

These agents inhibit inflammatory reactions and pain by decreasing activity of cyclooxygenase, which is responsible for prostaglandin synthesis. They generally are used in mild to moderately severe headaches; however, they also may be effective for severe headaches.
View full drug information Ibuprofen (Motrin, Advil)

First choice for treatment of headache, especially during pregnancy and breastfeeding.
View full drug information Naproxen sodium (Anaprox, Naprelan)

First choice for treatment of headache, especially during pregnancy and breastfeeding.

Antidepressants
Class Summary

These drugs increase the synaptic concentration of serotonin and/or norepinephrine in CNS by inhibiting their reuptake by the presynaptic neuronal membrane. Cymbalta can also be helpful for patients who have coexisting depression.
View full drug information Nortriptyline (Pamelor, Aventyl HCl)

Has demonstrated effectiveness in treatment of pain.

View full drug information Amitriptyline (Elavil)

Has demonstrated effectiveness in treatment of pain.

Serotonin reuptake inhibitors

Class Summary

These agents specifically inhibit presynaptic reuptake of serotonin. May be considered as an alternative to TCAs.
View full drug information Fluoxetine (Prozac)

Has potent specific 5-HT uptake inhibition with fewer anticholinergic and cardiovascular adverse effects than TCAs.
View full drug information Sertraline (Zoloft)

Atypical nontricyclic antidepressant with potent specific 5-HT uptake inhibition and fewer anticholinergic and cardiovascular adverse effects than TCAs.
View full drug information Paroxetine (Paxil)

Atypical nontricyclic antidepressant with potent specific 5-HT uptake inhibition and fewer anticholinergic and cardiovascular adverse effects than TCAs.

Electrolyte supplements
Class Summary

Electrolytes such as magnesium may help in the treatment of tension headache.

View full drug information Magnesium chloride (Slow-Mag, Mag-Delay)

Magnesium metabolism may have a significant role in both the etiology and the treatment of muscle contraction tension headache.

Patient Education
Advise the patient with tension-type headaches (TTHs) to take the following actions:

Avoid stressful situations if possible Maintain a regular sleep schedule Exercise regularly Eat balanced meals Avoid uncomfortable stressful positions and bad posture Avoid eyestrain Try biofeedback and relaxation techniques